Reglan (metoclopramide) is prescribed for short-term treatment of gastrointestinal disorders.
Four generic drug makers named as Defendants in a Reglan lawsuit that is pending in a USDCT in Vermont won't be granted an immediate appellate appeal the Trial Court’s decision not to grant a pending motion for summary judgment. The argument was that the generic makers did not develop the drug’s warning label.
The lawsuit was filed against Wyeth, which manufactured the drug metoclopramide under the brand name Reglan, and others including Teva Pharmaceuticals USA, Actavis Elizabeth, Barr Pharmaceuticals and Pliva.
You can read the opinion here, in PDF format. (D and B blog)
My office is investigating claims of injury related to Reglan, www.markzamora.com